Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection-free allograft survival.
Soares MA, Massie JP, Rifkin WJ, Rao N, Duckworth AM, Park C, Kadle RL, David JA, Rabbani PS, Ceradini DJ.
Soares MA, et al. Among authors: massie jp.
Am J Transplant. 2018 Jul;18(7):1657-1667. doi: 10.1111/ajt.14668. Epub 2018 Feb 19.
Am J Transplant. 2018.
PMID: 29359512
Free article.
Using an established rat hindlimb model for allotransplantation, we were able to significantly prolong rejection-free allograft survival with a single perioperative ex vivo infusion of bone marrow-derived mesenchymal stem cells through the allograft vasculature, in the absence of …
Using an established rat hindlimb model for allotransplantation, we were able to significantly prolong rejection-free allograft survival wit …